Businesses for Sale —
Your Goals Fuel Our Passion

We’re experts in selling businesses located throughout New England with revenues from $1 to $15 million. We’re passionate, committed and proven in helping business owners realize the rewards of their hard work over many years.

Deal Pending – Clinical Trial Research Business

Deal Pending – Clinical Trial Research Business
Listing:
1674
Deal Pending
Eastern Massachusetts
Revenue:
$729,000
Cash Flow:
$327,000
Asking Price:
$995,000
Business Description:

A successful clinical trial research company is available for sale. In the past 20 years, this business has performed over 150 clinical trials for several leading pharmaceutical manufacturers, including AbbVie, Sanofi Aventis and many Clinical Research Organizations (CRO’s). Revenues averaged $729,000 a year between 2018 and 2020 and the current pipeline of clinical trials is expected to generate over $2,000,000 in total revenues in 2021 and 2022. The business is well known and receives most clinical trial opportunities from a site management organization (SMO) and clinicaltrials.gov. They have done clinical trials in many therapeutic areas encompassing Women’s Health studies and Pulmonary Medicine. Their database of potential subjects contains over 400 individuals. The key employees have been with the company for several years. A new owner may be experienced and licensed as a researcher or may hire such individuals as needed. State licensure is required of the Principal Investigator/MD and Sub Investigators i.e., Nurse Practitioner or Physician Assistant for the company to conduct research at an independent level.

The current owner is selling due to retirement.

Growth Expansion and Opportunities:

The market for clinical trials has grown substantially over the past several years and it is expected to continue to enjoy good growth. By responding to more clinical trial opportunities from SMO’s and clinicaltrials.org, this business can continue to grow.

Support & Training:

The seller will provide training and support to ensure a smooth transition.

Broker:

Marc Gudema

Send Message to listing broker